Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss

v3.21.1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Income Statement [Abstract]    
Revenue $ 1,910 $ 1,468
Cost of revenue 675 831
Gross profit 1,235 637
Operating expenses:    
Sales and marketing 1,793 2,520
Research and development 603 711
General and administrative 1,978 2,187
Total operating expenses 4,374 5,418
Loss from operations (3,139) (4,781)
Other (expense) income, net:    
Interest expense (26) (52)
Gain on revaluation of warrant liabilities 11 2,519
Other expense, net (516) (220)
Total other (expense) income, net (531) 2,247
Net loss (3,670) (2,534)
Other comprehensive income 465 173
Comprehensive loss $ (3,205) $ (2,361)
Basic and diluted net loss per share applicable to common shareholders (in dollars per share) $ (0.34) $ (0.44)
Weighted average number of shares outstanding, basic and diluted (in shares) 10,752 5,803